Benefits of SGLT2i in heart failure across a broad range of ejection fractions: new opportunities and future challenges

被引:0
|
作者
Volpe, Massimo [1 ]
Patrono, Carlo [2 ]
机构
[1] Sapienza Univ Rome, St Andrea Hosp, Dept Cardiol, Rome, Italy
[2] Catholic Univ, Sch Med, Dept Pharmacol, Rome, Italy
关键词
SACUBITRIL/VALSARTAN;
D O I
10.1093/eurheartj/ehac649
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:178 / 179
页数:2
相关论文
共 50 条
  • [21] Growing role of SGLT2i in heart failure: evidence from clinical trials
    Varadhan, Ajay
    Stephan, Katarina
    Gupta, Rahul
    Vyas, Apurva V.
    Ranchal, Purva
    Aronow, Wilbert S.
    Hawwa, Nael
    Lanier, Gregg M.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (02) : 147 - 159
  • [22] EFFICACY OF SGLT2I IN ACUTE DECOMPENSATED HEART FAILURE WITH TYPE 2 DIABETES MELLITUS
    Long Doan
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E304 - E304
  • [23] Impact of SGLT2i on cardiovascular outcomes and heart failure in patients with type 2 diabetes
    Jose Rodriguez, Juan
    Ortega-Paz, Luis
    Brugaletta, Salvatore
    Sabate, Manel
    AIMS MEDICAL SCIENCE, 2018, 5 (01): : 67 - 79
  • [24] Improving management of heart failure with reduced ejection fraction with sglt2i's by exploring practical considerations: an online education intervention
    Sattin, S.
    Sendaydiego, A. M.
    EUROPEAN HEART JOURNAL, 2021, 42 : 781 - 781
  • [25] Heart Failure With "Mid-Range" Ejection Fraction-New Opportunities
    Lund, Lars H.
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (10) : 769 - 771
  • [26] Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients
    Michele Correale
    Olga Lamacchia
    Michele Ciccarelli
    Giuseppe Dattilo
    Lucia Tricarico
    Natale Daniele Brunetti
    Heart Failure Reviews, 2023, 28 : 733 - 744
  • [27] SGLT2i and Deterioration of Kidney Function in Heart Failure Another Demonstration for Tolerance of "Hypercreatininemia"
    Coca, Steven G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (19) : 1864 - 1867
  • [28] Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients
    Correale, Michele
    Lamacchia, Olga
    Ciccarelli, Michele
    Dattilo, Giuseppe
    Tricarico, Lucia
    Brunetti, Natale Daniele
    HEART FAILURE REVIEWS, 2023, 28 (03) : 733 - 744
  • [29] Improving management of heart failure with reduced ejection fraction with sglt2i's using the latest clinical data: an online education intervention
    Sattin, S.
    Sendaydiego, A. M.
    EUROPEAN HEART JOURNAL, 2021, 42 : 780 - 780
  • [30] Baseline characteristics and alterations after initiation of therapy with SGLT2i in a real-world heart failure with reduced ejection fraction population
    Stavrati, A.
    Polymeropoulos, K.
    Ioannidis, P.
    Kleitsioti, P.
    Lazaridis, P.
    Zarifis, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 163 - 163